Format

Send to

Choose Destination
Bone. 2014 Jun;63:47-52. doi: 10.1016/j.bone.2014.02.011. Epub 2014 Feb 26.

Viewpoints on vessels and vanishing bones in Gorham-Stout disease.

Author information

1
Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Lymphatic Malformation Institute, Bethesda, MD, USA. Electronic address: mdellinger@lmiresearch.org.
2
The Lymphatic Malformation Institute, Bethesda, MD, USA.
3
Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA, USA. Electronic address: bjorn_olsen@hms.harvard.edu.

Abstract

Gorham-Stout disease (GSD) is a rare disorder characterized by the proliferation of endothelial-lined vessels in bone and the progressive destruction of bone. Although Jackson described the first case of GSD in 1838, the clinical and histological features of GSD were not defined until Gorham and Stout published their report on massive osteolysis in 1955. In the years since Gorham and Stout's groundbreaking publication, more than 300 cases of GSD have been described in the literature. These reports have revealed that the progressive resorption of bone in GSD causes severe physical deformities, disabilities, and life-threatening complications. Unfortunately, the underlying cause of GSD remains unknown and, as a result, the therapeutic options for individuals with GSD are limited. Here we review the latest advances in GSD research and present strategies to address basic and clinical research questions related to GSD.

KEYWORDS:

Gorham–Stout disease; Lymphangiogenesis; Lymphangiomatosis; Osteolysis; Vanishing bone disease

PMID:
24583233
DOI:
10.1016/j.bone.2014.02.011
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center